Dr. Filmon Emnetu, PharmD, RPh, is the global clinical trial project manager at Eli Lilly.
What was your motivation to pursue the pharmaceutical industry as a career path?
My motivation to pursue a career in the pharmaceutical industry is rooted in my lifelong desire to make a genuine and lasting difference in the lives of patients around the world. Because the pharmaceutical sector plays a critical role in developing and delivering innovative therapies, I was naturally drawn to pursue a career in research and development. Working on phase 3 clinical trials affords me the opportunity to learn something new every day while simultaneously pursuing my goal of improving patient outcomes and health equity outcomes around the globe.
Talk about diversity, equity, and inclusion in the pharmaceutical industry; what should companies be doing to continue making progress?
To continue making progress in improving DEI initiatives within the pharmaceutical industry, companies should prioritize implementing comprehensive diversity initiatives, ensuring fair and inclusive hiring practices, and fostering a supportive and inclusive work environment for all employees. This includes actively seeking diverse talent, establishing mentorship and sponsorship programs for students and post-grads, promoting diversity at the leadership level, and regularly evaluating and addressing any disparities or biases within the organization. Additionally, collaboration with diverse patient communities and stakeholders can help ensure that medicines and healthcare solutions meet the needs of all individuals.
To learn more about IPhO, visit www.industrypharmacist.org.